Transcripts

Surrozen (SRZN) earnings call transcripts

Earnings call transcripts for Surrozen, Inc., with a summary, the guidance given, and what analysts pressed on.

  • conference, September 16, 2026

    Management framed the IND filing as a transition from Wnt platform science to clinical validation, emphasizing a dual-mechanism DME candidate and near-term funding and trial milestones.

    Sep 16, 2026Positive0.62